cell – media

IACS – An Advanced Cell Sorter

The technique of cell sorting can be used to study the cell structures and chromosome patterns. In the medical field cell sorting is used in cancer studies. For the past 50 years, cell sorting by flow cytometry based on phenotypic profiles has been widely used.
- Source: drugdu
- 782
- August 29, 2018
cell medtech Researches
Research Finds New Compounds to Reverse Key Aspects of Human Cell Aging

Research shows that chief aspects of the aging of human cells can be inverted by new compounds developed at the University of Exeter.
- Source: MedicalXpress
- 619
- August 12, 2018
aging cell Researches
Tessa Therapeutics Closes USD 80 Million Financing Round Led by Temasek

Tessa Therapeutics, an international clinical stage biopharmaceutical company focusing on T cell therapy for solid tumors, announced the completion of a USD 80 million financing round led by Temasek, an investment company headquartered in Singapore, and joined by EDBI, Karst Peak Capital, Heliconia, Heritas and other investors.
- Source: Prnewswire
- 450
- December 22, 2017
cell Market Views tumor
Breakthrough-Scientists reverse aging in human cells

New research published in the journal BMC Cell Biology shows that old human cells can be rejuvenated using chemicals similar to resveratrol, which is a substance found in red wine and dark chocolate.
- Source: medicalnewstoday
- 630
- November 9, 2017
cell Researches resveratrol
Cancer cells destroyed in just 3 days with new technique

Cancer cells are relentless, possessing the vexatious ability to develop resistance to current therapies and making the disease hugely challenging to treat. However, an exciting new study may have identified cancer's weak spot; the discovery has already led to the near-eradication of the disease in cell cultures.
- Source: medicalnewstoday
- 685
- November 8, 2017
cancer cell chromatin Researches
Cancer Startup Torque Therapeutics Nabs $21 Million and Sets Up Shop in Kendall Square

Torque Therapeutics has come out of stealth mode to launch with a $21 million Series A financing. It is looking to raise another $14 million, according to its filing with the U.S. Securities and Exchange Commission (SEC).
- Source: Biospace
- 846
- September 15, 2017
cell immune Series therapy
£2m UK consortium to tackle gene therapy

A two-year, £2 million project focused on gene and cell therapy manufacturing will be embarked on by Oxford BioMedica, will embark on.
- Source: news.open-medical
- 507
- August 14, 2017
cell Company Insight gene therapy

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.